Style | Citing Format |
---|---|
MLA | Shahali A, et al.. "Drug Repositioning Approach to Target Viral and Host Cells in Terms of Covid-19 Treatment: A Review of in Vivo Experiments and Clinical Studies." Journal of Experimental and Clinical Medicine (Turkey), vol. 39, no. 4, 2022, pp. 1255-1269. |
APA | Shahali A, Akbari V, Soltani R, Badri SS, Ardeshir RA (2022). Drug Repositioning Approach to Target Viral and Host Cells in Terms of Covid-19 Treatment: A Review of in Vivo Experiments and Clinical Studies. Journal of Experimental and Clinical Medicine (Turkey), 39(4), 1255-1269. |
Chicago | Shahali A, Akbari V, Soltani R, Badri SS, Ardeshir RA. "Drug Repositioning Approach to Target Viral and Host Cells in Terms of Covid-19 Treatment: A Review of in Vivo Experiments and Clinical Studies." Journal of Experimental and Clinical Medicine (Turkey) 39, no. 4 (2022): 1255-1269. |
Harvard | Shahali A et al. (2022) 'Drug Repositioning Approach to Target Viral and Host Cells in Terms of Covid-19 Treatment: A Review of in Vivo Experiments and Clinical Studies', Journal of Experimental and Clinical Medicine (Turkey), 39(4), pp. 1255-1269. |
Vancouver | Shahali A, Akbari V, Soltani R, Badri SS, Ardeshir RA. Drug Repositioning Approach to Target Viral and Host Cells in Terms of Covid-19 Treatment: A Review of in Vivo Experiments and Clinical Studies. Journal of Experimental and Clinical Medicine (Turkey). 2022;39(4):1255-1269. |
BibTex | @article{ author = {Shahali A and Akbari V and Soltani R and Badri SS and Ardeshir RA}, title = {Drug Repositioning Approach to Target Viral and Host Cells in Terms of Covid-19 Treatment: A Review of in Vivo Experiments and Clinical Studies}, journal = {Journal of Experimental and Clinical Medicine (Turkey)}, volume = {39}, number = {4}, pages = {1255-1269}, year = {2022} } |
RIS | TY - JOUR AU - Shahali A AU - Akbari V AU - Soltani R AU - Badri SS AU - Ardeshir RA TI - Drug Repositioning Approach to Target Viral and Host Cells in Terms of Covid-19 Treatment: A Review of in Vivo Experiments and Clinical Studies JO - Journal of Experimental and Clinical Medicine (Turkey) VL - 39 IS - 4 SP - 1255 EP - 1269 PY - 2022 ER - |